All Stories

  1. Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride

    Article • Diabetes Metabolic Syndrome and Obesity, August 2019, Taylor & Francis

    Owen Woodman

  2. Flavonols and Flavones – Protecting Against Myocardial Ischemia/ Reperfusion Injury by Targeting Protein Kinases

    Article • Current Medicinal Chemistry, December 2018, Bentham Science Publishers

    Owen Woodman

  3. Shear stress sensitizes TRPV4 in endothelium-dependent vasodilatation

    Article • Pharmacological Research, July 2018, Elsevier

    Owen Woodman

  4. Protection against reperfusion injury by 3′,4′-dihydroxyflavonol in rat isolated hearts involves inhibition of phospholamban and JNK2

    Article • International Journal of Cardiology, March 2018, Elsevier

    Owen Woodman

  5. 3′,4′-dihydroxyflavonol ameliorates endoplasmic reticulum stress-induced apoptosis and endothelial dysfunction in mice

    Article • Scientific Reports, January 2018, Springer Science + Business Media

    Owen Woodman

  6. A Functional Kinase Short Interfering Ribonucleic Acid Screen Using Protease-Activated Receptor 2-Dependent Opening of Transient Receptor Potential Vanilloid-4

    Article • Assay and Drug Development Technologies, January 2018, Mary Ann Liebert Inc

    Owen Woodman

  7. New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury

    Article • Current Drug Targets, October 2017, Bentham Science Publishers

    Owen Woodman

  8. Molecular Sensors of Blood Flow in Endothelial Cells

    Article • Trends in Molecular Medicine, September 2017, Elsevier

    Owen Woodman

  9. Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response

    Article • Endocrinology, August 2017, Endocrine Society

    Owen Woodman

  10. Western Diet Chow Consumption in Rats Induces Striatal Neuronal Activation While Reducing Dopamine Levels without Affecting Spatial Memory in the Radial Arm Maze

    Article • Frontiers in Behavioral Neuroscience, February 2017, Frontiers

    Owen Woodman

  11. Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice

    Article • Diabetes and Vascular Disease Research, February 2017, SAGE Publications

    Owen Woodman

  12. The HNO donor Angeli’s salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia–reperfusion injury in the rat heart ex vivo

    Article • Pharmacological Research, February 2016, Elsevier

    Owen Woodman

  13. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose

    Article • PLoS ONE, November 2015, PLOS

    Owen Woodman

  14. Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia–reperfusion injury by 3′,4′-dihydroxyflavonol

    Article • European Journal of Pharmacology, July 2015, Elsevier

    Owen Woodman

  15. Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction

    Article • Journal of Cardiovascular Pharmacology, June 2015, Wolters Kluwer Health

    Owen Woodman

  16. The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose

    Article • Pharmacological Research, April 2015, Elsevier

    Owen Woodman

  17. Cardioprotective potential of annexin-A1 mimetics in myocardial infarction

    Article • Pharmacology & Therapeutics, April 2015, Elsevier

    Owen Woodman

  18. Tocotrienol Rich Palm Oil Extract Is More Effective Than Pure Tocotrienols at Improving Endothelium-Dependent Relaxation in the Presence of Oxidative Stress

    Article • Oxidative Medicine and Cellular Longevity, January 2015, Hindawi Publishing Corporation

    Owen Woodman

  19. Microglia are Selectively Activated in Endocrine and Cardiovascular Control Centres in Streptozotocin-Induced Diabetic Rats

    Article • Journal of Neuroendocrinology, June 2014, Wiley

    Owen Woodman

  20. The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase‐dependent and ‐independent mechanisms

    Article • British Journal of Pharmacology, March 2014, Wiley

    Owen Woodman

  21. The flavonols quercetin and 3′,4′-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes

    Article • Diabetes and Vascular Disease Research, March 2014, SAGE Publications

    Owen Woodman

  22. The cardioprotectant 3′,4′-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats

    Article • Pharmacological Research, March 2014, Elsevier

    Owen Woodman

  23. Cardioprotective 3′,4′-dihydroxyflavonol attenuation of JNK and p38MAPKsignalling involves CaMKII inhibition

    Article • Biochemical Journal, December 2013, Portland Press Ltd.

    Owen Woodman

  24. Effect of type 1 diabetes on the production and vasoactivity of hydrogen sulfide in rat middle cerebral arteries

    Article • Physiological Reports, October 2013, Wiley

    Owen Woodman

  25. Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function

    Article • AJP Heart and Circulatory Physiology, March 2013, American Physiological Society

    John Hawley, Owen Woodman

  26. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3′,4′-dihydroxyflavonol and quercetin

    Article • Platelets, December 2012, Taylor & Francis

    Owen Woodman

  27. Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta

    Article • Pharmacological Research, November 2012, Elsevier

    Owen Woodman

  28. Treatment with quercetin and 3′,4′-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo

    Article • Journal of Thrombosis and Thrombolysis, October 2012, Springer Science + Business Media

    Owen Woodman

  29. Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, September 2012, Springer Science + Business Media

    Owen Woodman

  30. 2-Morpholinoisoflav-3-enes as flexible intermediates in the synthesis of phenoxodiol, isophenoxodiol, equol and analogues: Vasorelaxant properties, estrogen receptor binding and Rho/RhoA kinase pathway inhibition

    Article • Bioorganic & Medicinal Chemistry, April 2012, Elsevier

    Owen Woodman

  31. 3′,4′-Dihydroxyflavonol reduces vascular contraction through Ca2+ desensitization in permeabilized rat mesenteric artery

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, October 2011, Springer Science + Business Media

    Owen Woodman

  32. Antioxidant activity contributes to flavonol cardioprotection during reperfusion of rat hearts

    Article • Free Radical Biology and Medicine, October 2011, Elsevier

    Owen Woodman

  33. The ethanolic extract of Kaempferia parviflora reduces ischaemic injury in rat isolated hearts

    Article • Journal of Ethnopharmacology, September 2011, Elsevier

    Owen Woodman

  34. Synthesis of a hypoxia-targeted conjugate of the cardioprotective agent 3′,4′-dihydroxyflavonol and evaluation of its ability to reduce ischaemia/reperfusion injury

    Article • Bioorganic & Medicinal Chemistry Letters, September 2011, Elsevier

    Owen Woodman

  35. 3′,4′-Dihydroxyflavonol Antioxidant Attenuates Diastolic Dysfunction and Cardiac Remodeling in Streptozotocin-Induced Diabetic m(Ren2)27 Rats

    Article • PLoS ONE, July 2011, PLOS

    Owen Woodman

  36. 3′,4′-Dihydroxyflavonol Reduces Superoxide and Improves Nitric Oxide Function in Diabetic Rat Mesenteric Arteries

    Article • PLoS ONE, June 2011, PLOS

    Owen Woodman

  37. 3′,4′-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes

    Article • European Journal of Pharmacology, June 2011, Elsevier

    Owen Woodman

  38. Cardioprotection from ischaemia–reperfusion injury by a novel flavonol that reduces activation of p38 MAPK

    Article • European Journal of Pharmacology, May 2011, Elsevier

    Owen Woodman

  39. Water soluble flavonol prodrugs that protect against ischaemia-reperfusion injury in rat hindlimb and sheep heart

    Article • MedChemComm, January 2011, Royal Society of Chemistry

    Owen Woodman

  40. Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes

    Article • British Journal of Pharmacology, December 2010, Wiley

    Owen Woodman

  41. Comprehensive two-dimensional gas chromatography, retention indices and time-of-flight mass spectra of flavonoids and chalcones

    Article • Journal of Chromatography A, December 2010, Elsevier

    Owen Woodman

  42. Modulation of the Glucagon-Like Peptide-1 Receptor Signaling by Naturally Occurring and Synthetic Flavonoids

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2010, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Owen Woodman

  43. Effects of resveratrol and flavonols on cardiovascular function: Physiological mechanisms

    Article • BioFactors, August 2010, Wiley

    Owen Woodman

  44. Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery

    Article • AJP Heart and Circulatory Physiology, August 2010, American Physiological Society

    Owen Woodman

  45. High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy

    Article • Nutrition, July 2010, Elsevier

    Owen Woodman

  46. Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening

    Article • Molecular Pharmacology, June 2010, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Owen Woodman

  47. Effects of 3’,4’-dihydroxyflavonol on vascular contraction in rat aortic rings

    Article • Clinical and Experimental Pharmacology and Physiology, March 2010, Wiley

    Dr Spencer J Williams, Owen Woodman

  48. 3′,4′-Dihydroxyflavonol improves post-ischaemic coronary endothelial function following 7days reperfusion in sheep

    Article • European Journal of Pharmacology, December 2009, Elsevier

    Owen Woodman

  49. Antioxidants in the prevention of myocardial ischemia/reperfusion injury

    Article • Expert Review of Clinical Pharmacology, November 2009, Taylor & Francis

    Owen Woodman

  50. 3′,4′-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta

    Article • Life Sciences, July 2009, Elsevier

    Owen Woodman

  51. Annexin-1 peptide Anx-12-26 protects adult rat cardiac myocytes from cellular injury induced by simulated ischaemia

    Article • British Journal of Pharmacology, January 2009, Wiley

    Owen Woodman

  52. Discovery of Water‐Soluble Antioxidant Flavonols without Vasorelaxant Activity

    Article • ChemMedChem, October 2008, Wiley

    Dr Spencer J Williams, Owen Woodman

  53. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction

    Article • Life Sciences, April 2008, Elsevier

    Owen Woodman

  54. Using behaviour to predict stroke severity in conscious rats: Post-stroke treatment with 3′, 4′-dihydroxyflavonol improves recovery

    Article • European Journal of Pharmacology, April 2008, Elsevier

    Owen Woodman

  55. OESTROGEN AND VASCULOPROTECTION

    Article • Clinical and Experimental Pharmacology and Physiology, March 2008, Wiley

    Owen Woodman

  56. Understanding the Cardioprotective Effects of Flavonols: Discovery of Relaxant Flavonols without Antioxidant Activity

    Article • Journal of Medicinal Chemistry, March 2008, American Chemical Society (ACS)

    Owen Woodman

  57. Isoflavones, Equol and Cardiovascular Disease: Pharmacological and Therapeutic Insights

    Article • Current Medicinal Chemistry, November 2007, Bentham Science Publishers

    Owen Woodman

  58. TYPE 1 DIABETES AND HYPERCHOLESTEROLAEMIA REVEAL THE CONTRIBUTION OF ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR TO ENDOTHELIUM-DEPENDENT RELAXATION OF THE RAT AORTA

    Article • Clinical and Experimental Pharmacology and Physiology, October 2007, Wiley

    Owen Woodman

  59. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries

    Article • Brain Research, April 2007, Elsevier

    Owen Woodman

  60. The Red Wine Antioxidant Resveratrol Prevents Cardiomyocyte Injury Following Ischemia-Reperfusion Via Multiple Sites and Mechanisms

    Article • Antioxidants & Redox Signaling, January 2007, Mary Ann Liebert Inc

    Owen Woodman

  61. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes

    Article • Cardiovascular Research, October 2006, European Society of Cardiology

    Owen Woodman

  62. Sodium Nitroprusside Protects Adult Rat Cardiac Myocytes From Cellular Injury Induced by Simulated Ischemia

    Article • Journal of Cardiovascular Pharmacology, January 2006, Wolters Kluwer Health

    Owen Woodman

  63. Vasorelaxant and Antioxidant Activity of Flavonols and Flavones: Structure-Activity Relationships

    Article • Journal of Cardiovascular Pharmacology, September 2005, Wolters Kluwer Health

    Owen Woodman

  64. VASCULAR AND ANTI-OXIDANT ACTIONS OF FLAVONOLS AND FLAVONES

    Article • Clinical and Experimental Pharmacology and Physiology, November 2004, Wiley

    Owen Woodman

  65. Daidzein and 17β-Estradiol Enhance Nitric Oxide Synthase Activity Associated with an Increase in Calmodulin and a Decrease in Caveolin-1

    Article • Journal of Cardiovascular Pharmacology, August 2004, Wolters Kluwer Health

    Owen Woodman

  66. 3′,4′-Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep

    Article • British Journal of Pharmacology, June 2004, Wiley

    Owen Woodman

  67. ISCHAEMIA ENHANCES THE ROLE OF CA2+-ACTIVATED K+ CHANNELS IN ENDOTHELIUM-DEPENDENT AND NITRIC OXIDE-MEDIATED DILATATION OF THE RAT HINDQUARTERS VASCULATURE

    Article • Clinical and Experimental Pharmacology and Physiology, April 2004, Wiley

    Owen Woodman

  68. Selective vasodilator and chronotropic actions of 3′,4′-dihydroxyflavonol in conscious sheep

    Article • European Journal of Pharmacology, April 2004, Elsevier

    Owen Woodman

  69. Effect of Short-Term Phytoestrogen Treatment in Male Rats on Nitric Oxide-Mediated Responses of Carotid and Cerebral Arteries: Comparison with 17β-Estradiol

    Article • Journal of Pharmacology and Experimental Therapeutics, March 2004, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Owen Woodman

  70. Chronic treatment of male rats with daidzein and 17β-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation

    Article • British Journal of Pharmacology, January 2004, Wiley

    Owen Woodman

  71. 3′, 4′-Dihydroxyflavonol Enhances Nitric Oxide Bioavailability and Improves Vascular Function after Ischemia and Reperfusion Injury in the Rat

    Article • Journal of Cardiovascular Pharmacology, December 2003, Wolters Kluwer Health

    Owen Woodman

  72. Pharmacological approaches to preserving and restoring coronary endothelial function

    Article • Expert Opinion on Pharmacotherapy, November 2001, Informa Healthcare

    Owen Woodman

  73. Relaxation to Flavones and Flavonols in Rat Isolated Thoracic Aorta: Mechanism of Action and Structure-Activity Relationships

    Article • Journal of Cardiovascular Pharmacology, February 2000, Wolters Kluwer Health

    Owen Woodman

  74. Contribution Of Nitric Oxide, Cyclic Gmp And K+ Channels To Acetylcholine-Induced Dilatation Of Rat Conduit And Resistance Arteries

    Article • Clinical and Experimental Pharmacology and Physiology, January 2000, Wiley

    Owen Woodman

  75. Enhanced role for the opening of potassium channels in relaxant responses to acetylcholine after myocardial ischaemia and reperfusion in dog coronary arteries

    Article • British Journal of Pharmacology, February 1999, Wiley

    Owen Woodman

  76. Rabbit mononuclear leukocytes cause contraction of isolated aorta by the release of serotonin

    Article • Cardiovascular Research, January 1999, European Society of Cardiology

    Owen Woodman

  77. PRECONDITIONING IMPROVES MYOCARDIAL FUNCTION AND REFLOW, BUT NOT VASODILATOR REACTIVITY, AFTER ISCHAEMIA AND REPERFUSION IN ANAESTHETIZED DOGS

    Article • Clinical and Experimental Pharmacology and Physiology, August 1998, Wiley

    Owen Woodman

  78. Prevention of ischaemia-induced coronary vascular dysfunction

    Article • International Journal of Cardiology, December 1997, Elsevier

    Owen Woodman

  79. Effect of ischaemic preconditioning on vascular dysfunction induced by ischaemia and reperfusion in rat hindquarters

    Article • Cardiovascular Research, December 1996, European Society of Cardiology

    Owen Woodman

  80. The effect of ischaemia on endothelium-dependent vasodilatation and adrenoceptor-mediated vasoconstriction in rat isolated hearts

    Article • British Journal of Pharmacology, March 1996, Wiley

    Owen Woodman

  81. MODULATION OF VASOCONSTRICTION BY ENDOTHELIUM-DERIVED NITRIC OXIDE: THE INFLUENCE OF VASCULAR DISEASE

    Article • Clinical and Experimental Pharmacology and Physiology, September 1995, Wiley

    Owen Woodman

  82. Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs

    Article • British Journal of Pharmacology, June 1994, Wiley

    Owen Woodman

  83. Requirement for endothelium-derived nitric oxide in vasodilatation produced by stimulation of cholinergic nerves in rat hindquarters

    Article • British Journal of Pharmacology, June 1994, Wiley

    Owen Woodman

  84. INVOLVEMENT OF NITRIC OXIDE IN CORONARY VASCULAR RESPONSES TO 5-HYDROXYTRYPTAMINE IN THE ANAESTHETIZED GREYHOUND

    Article • Clinical and Experimental Pharmacology and Physiology, May 1994, Wiley

    Owen Woodman

  85. Cholinergic neurogenic vasodilatation is mediated by nitric oxide in the dog hindlimb

    Article • Cardiovascular Research, April 1994, European Society of Cardiology

    Owen Woodman

  86. Ischaemia/Reperfusion Enhances Phenylephrine-Induced Contraction of Rabbit Aorta Due to Impairment of Neuronal Uptake

    Article • Journal of Cardiovascular Pharmacology, April 1994, Wolters Kluwer Health

    Owen Woodman

  87. VASOCONSTRICTOR RESPONSES TO POLYMORPHONUCLEAR LEUCOCYTES FROM ATHEROSCLEROTIC RABBITS

    Article • Clinical and Experimental Pharmacology and Physiology, February 1994, Wiley

    Owen Woodman

  88. Impaired Vasodilator Function of Nitric Oxide Associated with Developing Neo-lntima in Conscious Rabbits

    Article • Journal of Vascular Research, January 1994, Karger Publishers

    Owen Woodman

  89. Myocardial ischaemia: What happens to the coronary arteries?

    Article • Trends in Pharmacological Sciences, December 1993, Elsevier

    Owen Woodman

  90. Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs

    Article • British Journal of Pharmacology, February 1993, Wiley

    Owen Woodman

  91. Involvement of dopamine in control of renal blood flow

    Article • Journal of the Autonomic Nervous System, November 1992, Elsevier

    Owen Woodman

  92. Baroreceptor reflexes and vascular reactivity during inhibition of nitric oxide synthesis in conscious rabbits

    Article • European Journal of Pharmacology, April 1992, Elsevier

    Owen Woodman

  93. Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol

    Article • British Journal of Pharmacology, March 1992, Wiley

    Owen Woodman

  94. The effect of hypercholesterolaemia and atherosclerosis on α-adrenoceptor-mediated vasoconstriction in conscious rabbits and rabbit aorta

    Article • European Journal of Pharmacology, February 1992, Elsevier

    Owen Woodman

  95. EFFECT OF TOLERANCE TO GLYCERYL TRINITRATE ON VASCULAR RESPONSES IN CONSCIOUS RABBITS

    Article • Clinical and Experimental Pharmacology and Physiology, June 1991, Wiley

    Owen Woodman

  96. N-nitro l-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilatation in anaesthetized greyhounds

    Article • British Journal of Pharmacology, June 1991, Wiley

    Owen Woodman

  97. ENHANCED VASOCONSTRICTION BY SEROTONIN IN RABBIT CAROTID ARTERIES WITH ATHEROMA-LIKE LESIONS IN VIVO

    Article • Clinical and Experimental Pharmacology and Physiology, May 1991, Wiley

    Owen Woodman

  98. Kinin receptors mediating the effects of bradykinin on the coronary circulation in anaesthetized greyhounds

    Article • European Journal of Pharmacology, April 1991, Elsevier

    Owen Woodman

  99. Coronary vascular responses to nicotine in the anaesthetized dog

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, January 1991, Springer Science + Business Media

    Owen Woodman

  100. Coronary vascular responses to nicotine In anaesthetized dogs

    Article • European Journal of Pharmacology, July 1990, Elsevier

    Owen Woodman

  101. Endothelium-dependent vasoconstriction induced by rabbit polymorphonuclear leucocytes

    Article • European Journal of Pharmacology, July 1990, Elsevier

    Owen Woodman

  102. Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs

    Article • British Journal of Pharmacology, May 1990, Wiley

    Owen Woodman

  103. Impaired vasodilatation of epicardial coronary arteries and resistance vessels following myocardial ischemia and reperfusion in anesthetized dogs

    Article • Coronary Artery Disease, May 1990, Wolters Kluwer Health

    Owen Woodman

  104. Noradrenaline-induced constriction of large and small coronary arteries in the anaesthetized dog

    Article • Journal of Autonomic Pharmacology, February 1989, Wiley

    Owen Woodman

  105. Adrenoceptor subtypes involved in the baroreceptor reflex constriction of large coronary arteries in the anaesthetized dog

    Article • European Journal of Pharmacology, December 1988, Elsevier

    Owen Woodman

  106. THE EFFECT OF THE CAROTID SINUS REFLEX ON LARGE CORONARY ARTERY DIAMETER IN ANAESTHETIZED DOGS

    Article • Clinical and Experimental Pharmacology and Physiology, December 1987, Wiley

    Owen Woodman

  107. The role of ?1- and ?2-adrenoceptors in the coronary vasoconstrictor responses to neuronally released and exogenous noradrenaline in the dog

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, August 1987, Springer Science + Business Media

    Owen Woodman

  108. Pericardial Release of Prostacyclin Induced by Bradykinin and Angiotensin II

    Article • Journal of Cardiovascular Pharmacology, November 1983, Wolters Kluwer Health

    Owen Woodman

  109. Prostacyclin produced by the pericardium and its influence on coronary vascular tone

    Article • The American Journal of Cardiology, July 1983, Elsevier

    Owen Woodman

  110. Coronary vasoconstriction induced by leukotrienes in the anaesthetized dog

    Article • European Journal of Pharmacology, December 1982, Elsevier

    Owen Woodman

  111. COMPARISON OF THE VASODILATOR ACTION OF DOPAMINE AND DOPAMINE AGONISTS IN THE RENAL AND CORONARY BEDS OF THE DOG

    Article • British Journal of Pharmacology, September 1982, Wiley

    Owen Woodman